Automated JAK2V617F quantification using a magnetic filtration system and sequence-specific primer-single molecule...

Area of Science:

• Hematology
• Molecular Diagnostics
• Genetics

Background:

• The janus activating kinase-2 (JAK2)(V617F) mutation is a key marker in chronic myeloproliferative disorders (CMPD).
• Accurate and efficient detection of this mutation is crucial for diagnosis and patient management.

Purpose of the Study:

• To establish and validate an automated system for detecting the JAK2(V617F) mutation.
• To assess the sensitivity and specificity of the developed system compared to conventional methods.

Main Methods:

• Development of an automated mutational analysis system combining magnetic filtration for DNA extraction and sequence-specific primer-single molecule fluorescence detection (SSP-SMFD) assay.
• Utilized artificial oligonucleotides for wild-type and mutated JAK2 sequences.
• Employed an automated fluorescence cell sorter for detection and quantification.

Main Results:

• The SSP-SMFD assay demonstrated a detection limit of 5% for the mutated JAK2(V617F) oligonucleotide.
• Analysis of 94 CMPD patients revealed discrepancies with PCR-direct sequencing, with the SSP-SMFD method identifying additional heterozygous JAK2(V617F) cases.
• The automated system showed high throughput suitability for JAK2 mutation detection.

Conclusions:

• The automated SSP-SMFD system provides a simple, high-throughput, and sensitive method for JAK2(V617F) mutation detection in CMPD.
• This technique offers improved diagnostic potential by identifying mutations missed by standard PCR-direct sequencing.
• The system's 5% detection threshold is valuable for identifying minimal residual disease or low-level mosaicism.